摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-benzyl-3-hydroxy-pent-4-enoic acid | 479496-23-6

中文名称
——
中文别名
——
英文名称
2-benzyl-3-hydroxy-pent-4-enoic acid
英文别名
(3R,2R)-2-benzyl-3-hydroxypent-4-enoic acid;(2R,3R)-2-benzyl-3-hydroxypent-4-enoic acid
2-benzyl-3-hydroxy-pent-4-enoic acid化学式
CAS
479496-23-6
化学式
C12H14O3
mdl
——
分子量
206.241
InChiKey
SHGJKDSOULCLQK-GHMZBOCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-benzyl-3-hydroxy-pent-4-enoic acid哌啶 、 rink amide AM resin 吡啶RuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh)4-二甲氨基吡啶 、 lithium hydroxide 、 氢氟酸双氧水1-羟基苯并三唑 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺N,N'-二环己基碳二亚胺 作用下, 以 四氢呋喃二氯甲烷甲苯 为溶剂, 反应 4.83h, 生成 (Z)-8-amino-2-benzyl-3,7-dihydroxy-9-(4-hydroxy-phenyl)-non-4-enoic acid (1-carbamoyl-2-phenyl-ethyl)-amide
    参考文献:
    名称:
    High-Affinity Mu Opioid Receptor Ligands Discovered by the Screening of an Exhaustively Stereodiversified Library of 1,5-Enediols
    摘要:
    In this communication, we report the synthesis of an exhaustively stereodiversified library of 16 1,5-enediols (2) and the screening of these compounds for mu opioid receptor (MOR) binding. The stereochemical configuration of 2 strongly impacted the binding affinity, and (S,S,S,R)-2 exhibited a Ki of 8.8 nM for MOR, comparable to that of endomorphin-2 (Ki = 1.2 nM). Moreover, compounds 2 exhibited 5-86-fold selectivity for MOR over delta opioid receptor (DOR) and 16-150-fold selectivity for MOR over kappa opioid receptor (KOR). Additionally, analogues of 2 were synthesized which showed the importance of the trans olefin for receptor binding but that modifications of the C-terminal amino acid were well tolerated. Ligand 11 is noteworthy because it retains only one of the amide bonds present in 1, but binds MOR with an affinity of 10 nM and 110- and 600-fold selectivity for MOR over DOR and KOR. These results demonstrate the utility of stereochemical diversity in the discovery of bioactive small molecules.
    DOI:
    10.1021/ja027150p
  • 作为产物:
    描述:
    丙烯醛三乙胺双环己基(三氟甲烷磺酰氧基)硼烷sodium hydroxide 作用下, 以 二氯甲烷甲醇 为溶剂, 以70%的产率得到2-benzyl-3-hydroxy-pent-4-enoic acid
    参考文献:
    名称:
    [EN] MU OPIOID RECEPTOR LIGANDS: METHODS OF USE AND SYNTHESIS
    [FR] LIGANDS DE RECEPTEUR OPIOIDE MU: PROCEDES D'UTILISATION ET DE SYNTHESE
    摘要:
    本文描述了从芳基取代的8-氨基-3,7-或3,6-二羟基烯酸或烷酸衍生的肽类模拟化合物,以及包括这些化合物的组合物,以及使用和制备这些化合物的方法。这些化合物在治疗应用中很有用,包括调节受试者(例如,哺乳动物、人类、狗、猫、马)的疾病症状。这些化合物通过它们与μ阿片受体(MOR)的结合亲和力在调节MOR方面很有用。
    公开号:
    WO2004033414A1
点击查看最新优质反应信息

文献信息

  • Mu opioid receptor ligands: methods of use and synthesis
    申请人:Harrison Bryce A.
    公开号:US20090093534A1
    公开(公告)日:2009-04-09
    Novel compounds and compositions including those compounds, as well as methods of using and making the compounds are herein described. The compounds are useful in therapeutic applications, including modulation of disease or disease symptoms in a subject (e.g., mammal, human, dog, cat, horse). The compounds are useful as modulators of the mu opioid receptor (MOR) through their binding affinity with that receptor.
    本文描述了包括这些化合物在内的新型化合物和组合物,以及使用和制造这些化合物的方法。这些化合物在治疗应用中有用,包括调节受试者(例如哺乳动物、人类、狗、猫、马)的疾病或疾病症状。这些化合物通过它们与μ阿片受体(MOR)的结合亲和力作为MOR的调节剂是有用的。
  • US7223888B2
    申请人:——
    公开号:US7223888B2
    公开(公告)日:2007-05-29
  • US7759514B2
    申请人:——
    公开号:US7759514B2
    公开(公告)日:2010-07-20
  • High-Affinity Mu Opioid Receptor Ligands Discovered by the Screening of an Exhaustively Stereodiversified Library of 1,5-Enediols
    作者:Bryce A. Harrison、Tiffany Malinky Gierasch、Claire Neilan、Gavril W. Pasternak、Gregory L. Verdine
    DOI:10.1021/ja027150p
    日期:2002.11.1
    In this communication, we report the synthesis of an exhaustively stereodiversified library of 16 1,5-enediols (2) and the screening of these compounds for mu opioid receptor (MOR) binding. The stereochemical configuration of 2 strongly impacted the binding affinity, and (S,S,S,R)-2 exhibited a Ki of 8.8 nM for MOR, comparable to that of endomorphin-2 (Ki = 1.2 nM). Moreover, compounds 2 exhibited 5-86-fold selectivity for MOR over delta opioid receptor (DOR) and 16-150-fold selectivity for MOR over kappa opioid receptor (KOR). Additionally, analogues of 2 were synthesized which showed the importance of the trans olefin for receptor binding but that modifications of the C-terminal amino acid were well tolerated. Ligand 11 is noteworthy because it retains only one of the amide bonds present in 1, but binds MOR with an affinity of 10 nM and 110- and 600-fold selectivity for MOR over DOR and KOR. These results demonstrate the utility of stereochemical diversity in the discovery of bioactive small molecules.
  • [EN] MU OPIOID RECEPTOR LIGANDS: METHODS OF USE AND SYNTHESIS<br/>[FR] LIGANDS DE RECEPTEUR OPIOIDE MU: PROCEDES D'UTILISATION ET DE SYNTHESE
    申请人:HARVARD COLLEGE
    公开号:WO2004033414A1
    公开(公告)日:2004-04-22
    Peptidomimetic compounds derived from aralkyl substitued 8-amino-3,7- or 3,6-dihydroxy alkenoic or alkanoic acids and compositions including those compounds, as well as methods of using and making the compounds are herein described. The compounds are useful in therapeutic applications, including modulation of disease symptoms in a subject (e.g., mammal, human, dog, cat, horse). The compounds are useful as modulators of the mu opioid receptor (MOR) through their binding affinity with that receptor.
    本文描述了从芳基取代的8-氨基-3,7-或3,6-二羟基烯酸或烷酸衍生的肽类模拟化合物,以及包括这些化合物的组合物,以及使用和制备这些化合物的方法。这些化合物在治疗应用中很有用,包括调节受试者(例如,哺乳动物、人类、狗、猫、马)的疾病症状。这些化合物通过它们与μ阿片受体(MOR)的结合亲和力在调节MOR方面很有用。
查看更多